Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized Clinical Trial

Chinese multicentre phase II placebo-controlled trial of eight weeks of treatment in patients managed without surgery.

Highlights

Index entry — verify clinical detail against the primary source.

Related conditions

For learning and professional reference; not a patient-specific recommendation. How we prepare content.